Allied Corp
Allied Corp., a cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States. The company operates in two segments, Allied Colombia and Allied Corp. It offers hemp-based CBD natural health products, as well as cannabis related products, including beauty and skincare products, and foods and beverages. The company also develops ALID 10 and ALID 11 for th… Read more
Allied Corp (ALID) - Net Assets
Latest net assets as of November 2024: $-7.64 Million USD
Based on the latest financial reports, Allied Corp (ALID) has net assets worth $-7.64 Million USD as of November 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.95 Million) and total liabilities ($9.59 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-7.64 Million |
| % of Total Assets | -391.71% |
| Annual Growth Rate | N/A |
| 5-Year Change | -303.78% |
| 10-Year Change | N/A |
| Growth Volatility | 296.85 |
Allied Corp - Net Assets Trend (2016–2024)
This chart illustrates how Allied Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Allied Corp (2016–2024)
The table below shows the annual net assets of Allied Corp from 2016 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-08-31 | $-7.55 Million | -9.64% |
| 2023-08-31 | $-6.88 Million | -436.84% |
| 2022-08-31 | $-1.28 Million | -32.10% |
| 2021-08-31 | $-970.78K | -126.21% |
| 2020-08-31 | $3.70 Million | +6294.36% |
| 2019-08-31 | $-59.80K | -62.98% |
| 2018-08-31 | $-36.69K | -110.41% |
| 2017-08-31 | $-17.44K | -719.91% |
| 2016-08-31 | $2.81K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Allied Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4956233300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $42.04 Million | % |
| Total Equity | $-7.55 Million | 100.00% |
Allied Corp Competitors by Market Cap
The table below lists competitors of Allied Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guardforce AI Co. Limited
PINK:GRDAF
|
$1.44 Million |
|
Combined Motor Holdings Limited
JSE:CMH
|
$1.44 Million |
|
Bronco Resources Corp.
V:BRON
|
$1.44 Million |
|
HUMANA - Dusseldorf Stock Exchang
DU:HUM
|
$1.44 Million |
|
Discovery Alaska Ltd
AU:DAF
|
$1.44 Million |
|
Quality Industrial Corp.
PINK:QIND
|
$1.44 Million |
|
Banaras Beads Limited
NSE:BANARBEADS
|
$1.44 Million |
|
Troubadour Resources Inc
OTCQB:TROUF
|
$1.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Allied Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -6,884,463 to -7,548,464, a change of -664,001.
- Net loss of 3,976,184 reduced equity.
- New share issuances of 1,939,343 increased equity.
- Other factors increased equity by 1,372,840.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.98 Million | -52.68% |
| Share Issuances | $1.94 Million | +25.69% |
| Other Changes | $1.37 Million | +18.19% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Allied Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-08-31 | $0.00 | $0.02 | x |
| 2017-08-31 | $0.00 | $0.02 | x |
| 2018-08-31 | $0.01 | $0.02 | x |
| 2019-08-31 | $0.00 | $0.02 | x |
| 2020-08-31 | $0.04 | $0.02 | x |
| 2021-08-31 | $-0.01 | $0.02 | x |
| 2022-08-31 | $-0.01 | $0.02 | x |
| 2023-08-31 | $-0.07 | $0.02 | x |
| 2024-08-31 | $-0.07 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Allied Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4134.11%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-37.93%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -73.34% | 0.00% | 0.00x | 2.54x | $-2.34K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-18.51K |
| 2018 | -89.66% | 0.00% | 0.00x | 0.00x | $-488.63K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-17.13K |
| 2020 | -178.39% | 0.00% | 0.00x | 1.92x | $-6.98 Million |
| 2021 | 0.00% | -91749.85% | 0.00x | 0.00x | $-11.39 Million |
| 2022 | 0.00% | -9383.59% | 0.03x | 0.00x | $-15.41 Million |
| 2023 | 0.00% | -14807.58% | 0.03x | 0.00x | $-9.99 Million |
| 2024 | 0.00% | -4134.11% | 0.05x | 0.00x | $-3.22 Million |
Industry Comparison
This section compares Allied Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Allied Corp (ALID) | $-7.64 Million | -73.34% | N/A | $1.44 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |